Pharmaceutical News

RSS

New sunscreen protects against both UVA and UVB rays

People will now be able to get better protection from the sun with a new sunscreen recently approved by the U.S. Food and Drug Administration (FDA).

27 Jul 2006

New bird flu vaccine has 80% protection rate

According to the manufacturer the latest bird flu vaccine is more than 80% effective in protecting people against the virus.

26 Jul 2006

Remicade receives European approval for treatment of psoriatic arthritis

Schering-Plough Corporation today announced that the European Commission has approved the use of Remicade (infliximab) as monotherapy in the treatment of active and progressive psoriatic arthritis (PsA) in patients who show intolerance to methotrexate or for whom methotrexate is contraindicated.

26 Jul 2006

NICE backs use of Enbrel and Raptiva to treat severe psoriasis

NICE has today issued guidance for the use of the targeted biological therapies, Enbrel (etanercept) and Raptiva (efalizumab), to treat adult patients with severe plaque psoriasis.

26 Jul 2006

GSK reports significant advance in H5N1 pandemic flu vaccine programme

GlaxoSmithKline (GSK) today announced headline data showing that its H5N1 pandemic flu vaccine achieved a high immune response at a low dose of antigen.

26 Jul 2006

New OTC sunscreen product approved by FDA

FDA has approved Anthelios SX, a sunscreen from L'Oreal to be sold over-the-counter (OTC) for the prevention of sunburn and for protection against ultraviolet B (UVB) and ultraviolet A (UVA) rays.

25 Jul 2006

FDA approves Elaprase (idursulfase) for Hunter syndrome

The U.S. Food and Drug Administration (FDA) has approved Elaprase (idursulfase), the first product for the treatment of Hunter syndrome (Mucopolysaccharidosis II, or MPS II).

25 Jul 2006

FDA expands use of Oncaspar to include treating children and adults with newly diagnosed acute lymphoblastic leukemia

The U.S. Food and Drug Administration (FDA) has expanded the approved use of Oncaspar to include treating children and adults with newly diagnosed acute lymphoblastic leukemia (ALL) as part of a multiple drug chemotherapy regimen.

25 Jul 2006

Nexavar approved in Europe for treatment of advanced kidney cancer

Bayer Pharmaceuticals Corporation and Onyx Pharmaceuticals, Inc have announced that the European Commission has granted marketing authorization to Nexavar (sorafenib) tablets for the treatment of patients with advanced renal cell carcinoma.

24 Jul 2006

FDA warns against use of "bismacine," also known as chromocine

The U.S. Food & Drug Administration (FDA) is warning consumers and health care providers not to use a product called "bismacine," also known as chromocine.

21 Jul 2006

New 'patch' drug therapy for Alzheimer's has fewer side effects

Alzheimer's, is the most common form of dementia and affects as many as 15 million people worldwide.

20 Jul 2006

New guidelines for antiepileptic drugs

The International League Against Epilepsy has set new treatment guidelines for antiepileptic drugs, as published in the journal Epilepsia.

19 Jul 2006

Ranbaxy to acquire the Mundogen generic business from GlaxoSmithKline

Ranbaxy, India's largest pharmaceutical company, and among the top ten generic pharmaceutical companies in the world, announced today that the Company has acquired the Mundogen generic business of GlaxoSmithKline.

19 Jul 2006

Canada ready to vaccinate against human papillomavirus

Canadian women will soon be able to access the first vaccine to protect against the sexually transmitted virus that causes cervical cancer.

19 Jul 2006

FDA gives the green light for Gemzar to treat recurrent ovarian cancer

Drug company Eli Lilly has been given approval by the U.S. Food and Drug Administration (FDA) for its drug Gemzar to be used by women living with recurrent ovarian cancer.

18 Jul 2006

FDA approval for Gemzar for ovarian cancer

Eli Lilly and Company announced that the United States Food and Drug Administration (FDA) has approved Gemzar (gemcitabine HCl) for use in the treatment of women living with recurrent ovarian cancer.

18 Jul 2006

FDA approves Implanon (etonogestrel implant) contraceptive

Organon announced today that the U.S. Food and Drug Administration (FDA) approved Implanon (etonogestrel implant) 68mg, the first and only single-rod implantable contraceptive that is effective for up to three years.

18 Jul 2006

Memory Pharmaceuticals achieves milestone for the treatment of neurological and psychiatric disorders

Memory Pharmaceuticals is to receive approximately $2.3M in funding from Roche in 2007.

17 Jul 2006

FDA approves Atripla for the treatment of HIV-1 infection in adults

Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.

13 Jul 2006

Bayer's takeover offer for Schering AG complete

Bayer's public takeover offer for Schering AG has been completed. Following expiration of the additional acceptance period, Bayer now has control of 92.4 percent of the approximately 191 million outstanding Schering shares.

13 Jul 2006